Programmatic treatment outcomes in HIV-infected and uninfected drug-resistant TB patients in Khayelitsha, South Africa
OUTPUT TYPE: Journal Article
PUBLICATION YEAR: 2015
TITLE AUTHOR(S): E.Mohr, V.Cox, L.Wilkinson, S.Moyo, J.Hughes, J.Daniels, O.Muller, H.Cox
KEYWORDS: HIV/AIDS, KHAYELITSHA, TREATMENT CENTRES, TUBERCULOSIS, WESTERN CAPE PROVINCE
DEPARTMENT: Public Health, Societies and Belonging (HSC)
Print: HSRC Library: shelf number 8844
HANDLE: 20.500.11910/1759
URI: http://hdl.handle.net/20.500.11910/1759
If you would like to obtain a copy of this Research Output, please contact Hanlie Baudin at researchoutputs@hsrc.ac.za.
Abstract
South Africa has high burdens of HIV, TB and drug-resistant TB (DR-TB, rifampicin-resistance). Treatment outcome data for HIV-infected versus uninfected patients is limited. We assessed the impact of HIV and other factors on DR-TB treatment success, time to culture conversion, loss-from-treatment and overall mortality after second-line treatment initiation. A retrospective cohort analysis was conducted for patients initiated on DR-TB treatment from 2008 to 2012, within a community-based, decentralised programme in Khayelitsha, South Africa. Among 853 confirmed DR-TB patients initiating second-line treatment, 605 (70.9%) were HIV infected. HIV status did not impact on time to sputum culture conversion nor did it impact treatment success; 48.1% (259/539) and 45.9% (100/218), respectively (p=0.59). In a multivariate model, HIV was not associated with treatment success. Death during treatment was higher among HIV-infected patients, but overall mortality was not significantly higher. HIV-infected patients with CD4 100 cells/ml were significantly more likely to die after starting treatment. Response to DR-TB treatment did not differ with HIV infection in a programmatic setting with access to antiretroviral treatment (ART). Earlier ART initiation at a primary care level could reduce mortality among HI infected patients presenting with low CD4 counts.-
Related Research Outputs:
- Pyridoxal-5-phosphate plasma concentrations in children receiving tuberculosis chemotherapy including isoniazid
- Factors associated with tuberculosis reinfection and treatment failure in Taung sub-district, South Africa
- TB and HIV/TB co-infection: adherence to drug treatment in three selected provinces in South Africa
- Drug-resistant TB treatment: concerns over absconding patients
- HIV/AIDS, tuberculosis and parasites
- HIV/AIDS/STI/TB knowledge, beliefs and practices of traditional healers in KwaZulu-Natal, South Africa
- A controlled study of an HIV/AIDS/STI/TB intervention with traditional healers in KwaZulu-Natal, South Africa
- HIV/AIDS/STI/TB knowledge, attitudes and practices among lay health workers and nurses in KwaZulu-Natal, South Africa
- Social constructions of gender roles, gender-based violence and HIV/AIDS in two communities of the Western Cape, South Africa
- Report and policy brief from the 4th Africa Conference on social aspects of HIV/AIDS research: innovations in access to prevention, treatment and care in HIV/AIDS, Kisumu, Kenya, 29 April-3 May 2007
- Gender, power and resistance to change among two communities in the Western Cape, South Africa
- Bayesian approach in estimating risk determinants of infectious diseases
- TB and HIV/AIDS epidemics in South Africa: an overview
- Rifampin pharmacokinetics in children, with and without human immunodefiency virus infection, hospitalized for the management of severe forms of tuberculosis
- Utilisation of the national antiretroviral therapy guidelines among health care professionals working in Abuja treatment centres, Nigeria
- Stigma, culture, and HIV and AIDS in the Western Cape, South Africa: an application of the PEN-3 cultural model for community-based research
- Chronic cough and its association with TB-HIV co-infection: factors affecting help-seeking behaviour in Harare, Zimbabwe
- The who & why of antiretroviral treatment adherence
- Filling a gap: HIV pediatric surveillance in resource contrained settings
- Translating research into practice: the implementation of options for health: Western Cape